Lebowitz M S, Pedersen P L
Department of Biological Chemistry, Johns Hopkins School of Medicine, Baltimore, Maryland 21205.
Arch Biochem Biophys. 1993 Feb 15;301(1):64-70. doi: 10.1006/abbi.1993.1115.
The ATPase inhibitor protein of the rat liver mitochondrial ATP synthase/ATPase complex has been cloned from a rat liver cDNA library, and its nucleotide sequence determined. The sequence is highly homologous to both the bovine heart (approximately 70%) and the yeast inhibitor proteins (approximately 40%). The deduced protein sequence is 107 amino acids in length, and based on homology to the bovine heart protein, the first 25 N-terminal amino acids encode a putative mitochondrial targeting sequence. The "mature" protein (without the targeting sequence) fused to the maltose binding protein has been overexpressed in Escherichia coli. The maltose binding protein was used as a handle for the development of a rapid one-step purification of the fusion protein by affinity chromatography on an amylose resin. The purified fusion protein was cleaved with Factor Xa protease at the fusion junction, and the resulting ATPase inhibitor protein was purified to > 90% purity. The purified, overexpressed inhibitor protein displays normal inhibitor activity. The protein inhibits ATP hydrolysis catalyzed by the ATP synthase/ATPase complex in submitochondrial particles in a manner kinetically indistinguishable from the same protein purified from rat liver mitochondria, and exhibits a specific activity of approximately 10,000 units/mg. The secondary structure of the inhibitor protein was determined by circular dichroism spectropolarimetry. The experimentally determined structure shows a high content of alpha-helix and is in good agreement with sequence-based structural predictions. As the function of the inhibitor protein is known to exhibit a high dependence on pH, a study of the pH dependence of inhibitor secondary structure was performed. It is shown that as pH is lowered, conditions which activate inhibitory capacity, the protein loses significant alpha-helical structure. This is the first report of the overexpression in E. coli of a functional ATPase inhibitor protein. Secondary structural analysis of this protein indicates that conversion from its active to its inactive form involves a significant conformational change.
大鼠肝脏线粒体ATP合酶/ATP酶复合物的ATP酶抑制蛋白已从大鼠肝脏cDNA文库中克隆出来,并测定了其核苷酸序列。该序列与牛心的抑制蛋白(约70%)和酵母抑制蛋白(约40%)高度同源。推导的蛋白质序列长度为107个氨基酸,基于与牛心蛋白的同源性,前25个N端氨基酸编码一个假定的线粒体靶向序列。与麦芽糖结合蛋白融合的“成熟”蛋白(无靶向序列)已在大肠杆菌中过表达。麦芽糖结合蛋白被用作一个工具,用于通过在直链淀粉树脂上进行亲和层析来快速一步纯化融合蛋白。纯化的融合蛋白在融合连接处用因子Xa蛋白酶切割,得到的ATP酶抑制蛋白被纯化至纯度>90%。纯化的、过表达的抑制蛋白表现出正常的抑制活性。该蛋白抑制亚线粒体颗粒中ATP合酶/ATP酶复合物催化的ATP水解,其动力学方式与从大鼠肝脏线粒体中纯化的相同蛋白无法区分,并且具有约10000单位/毫克的比活性。抑制蛋白的二级结构通过圆二色光谱偏振法测定。实验测定的结构显示α-螺旋含量很高,与基于序列的结构预测结果吻合良好。由于已知抑制蛋白的功能对pH高度依赖,因此对抑制蛋白二级结构的pH依赖性进行了研究。结果表明,随着pH降低,即激活抑制能力的条件下,该蛋白会失去大量的α-螺旋结构。这是关于功能性ATP酶抑制蛋白在大肠杆菌中过表达的首次报道。该蛋白的二级结构分析表明,从其活性形式转变为非活性形式涉及显著的构象变化。